ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 112 filers reported holding ENDOLOGIX INC in Q2 2017. The put-call ratio across all filers is 63.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $309,000 | -60.7% | 433,335 | +4.8% | 0.00% | – |
| Q3 2018 | $787,000 | -56.1% | 413,412 | +30.5% | 0.00% | -100.0% |
| Q2 2018 | $1,791,000 | +170.5% | 316,676 | +101.3% | 0.00% | – |
| Q1 2018 | $662,000 | -35.0% | 157,315 | -17.6% | 0.00% | -100.0% |
| Q4 2017 | $1,019,000 | +154.8% | 190,868 | +111.7% | 0.00% | – |
| Q3 2017 | $400,000 | -56.1% | 90,165 | -51.9% | 0.00% | -100.0% |
| Q2 2017 | $911,000 | -80.7% | 187,626 | -71.3% | 0.00% | -66.7% |
| Q1 2017 | $4,726,000 | +20.3% | 653,002 | -5.0% | 0.00% | 0.0% |
| Q4 2016 | $3,929,000 | -11.1% | 687,289 | +99.0% | 0.00% | 0.0% |
| Q3 2016 | $4,419,000 | +59.6% | 345,361 | +55.3% | 0.00% | +50.0% |
| Q2 2016 | $2,768,000 | +146.7% | 222,332 | +65.5% | 0.00% | +100.0% |
| Q1 2016 | $1,122,000 | -23.9% | 134,356 | -10.0% | 0.00% | 0.0% |
| Q4 2015 | $1,475,000 | -24.0% | 149,215 | -5.9% | 0.00% | -50.0% |
| Q3 2015 | $1,942,000 | -8.0% | 158,530 | +15.1% | 0.00% | +100.0% |
| Q2 2015 | $2,111,000 | +5.8% | 137,708 | +17.7% | 0.00% | 0.0% |
| Q1 2015 | $1,996,000 | +68.6% | 117,024 | +51.0% | 0.00% | 0.0% |
| Q4 2014 | $1,184,000 | +28.8% | 77,525 | -10.7% | 0.00% | 0.0% |
| Q3 2014 | $919,000 | -31.1% | 86,793 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,333,000 | +20.7% | 87,679 | +2.1% | 0.00% | 0.0% |
| Q1 2014 | $1,104,000 | -26.5% | 85,916 | -0.3% | 0.00% | 0.0% |
| Q4 2013 | $1,502,000 | -34.8% | 86,151 | -39.7% | 0.00% | -50.0% |
| Q3 2013 | $2,303,000 | – | 142,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|